Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Western Investment Company Announces Rights Offering
-
KUBRA & Silverblaze Partner to Upgrade Billing, Payment, and Customer Engagement Solutions
-
Easterly Asset Management Appoints Tom Aitken and Peter Mastropietro as Senior Vice Presidents of Private Market Sales
-
Global Crossing Airlines Appoints Laurie Villa as Chief People Officer
-
Health Recovery Solutions Partners with Smart Meter to Provide Cost-Effective Cellular Remote Patient Monitoring for the Home
-
Garrett Motion to Hold Third Quarter 2024 Financial Results Conference Call on Thursday October 24, 2024
-
Intellia Therapeutics Announces Initiation of HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
-
MariMed Announces Third Quarter 2024 Earnings Date
-
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Highwire Taps Katherine Zackel to Lead Crisis
-
SemiCab Wins Contract with $200 Billion Global Consumer Packaged Goods Company for New US Pilot
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
BNP Paribas Primary New Issues: Sammontana No STAB Notice
-
Alliance Trust PLC - Net Asset Value
-
RCG Global Services Acquires Aethereus to Strengthen Salesforce and Data Services
-
Atlas Salt Announces CFO Transition, Project Progress and Investor Relations Campaign
-
Happy Belly Appoints Former Vice President - Growth & Operations of FRESH Restaurants Randall Papineau as Brand President of IQ Foods
-
ecozy Launches New Commercial Ice Makers, Marking a New Era in Ice Production Solutions for Homes and Businesses
-
RedMane Introduces New mCase Capabilities To Further Automate and Enhance the Capabilities of Health and Human Services Programs
-
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
-
Consortium Led by Mason Capital Management to Acquire CB&I From McDermott
-
The Duckhorn Portfolio Announces Fourth Quarter and Fiscal Year 2024 Financial Results
-
GPOPlus Expands Distribution Network With Texas Born Stores
-
Affluence Corporation Update and Unwind Agreement Finalized
-
Flying Nickel Closes 2nd Tranche of Non-Brokered Private Placement Raising Gross Proceeds of $58,000 and Appoints Chief Legal Officer
-
Theralase(R) Provides Update on Bladder Cancer Clinical Study
-
Silver Elephant Announces $490,000 Non-Brokered Private Placement and Appoints Chief Legal Officer
-
Fury Samples High-Grade Lithium from Outcrop at Éléonore South
-
Oracle Commodity Holding Appoints Chief Legal Officer
-
Atlas Lithium Advances Its Salinas Project
-
Geophysical Survey Conducted at AurMac Gold Project, Yukon
-
Plurilock Announces US$1.7 Million Cybersecurity Sale to Major Semiconductor Manufacturer
-
GPM Metals Announces Upsize to Previously Announced Non-Brokered Private Placement of Up to C$660,000
-
Magna Mining Provides Update on the Surface Advanced Exploration Bulk Sampling Program at the Crean Hill Project and Corporate Update
-
Consensus Cloud Solutions to Host Q3 Investor Call on November 7, 2024
-
Sharing the Lifesaving Impact of Plasma Donation During International Plasma Awareness Week 2024
-
Judo Bio Unveils Data Demonstrating Receptor-mediated Delivery of Oligonucleotides to the Kidney
-
Clough Global Opportunities Fund Declares Monthly Cash Distributions for October, November and December of $0.0480 Per Share
-
Clough Global Equity Fund Declares Monthly Cash Distributions for October, November and December of $0.0603 Per Share
-
Clough Global Dividend and Income Fund Declares Monthly Cash Distributions for October, November and December 2024 of $0.0526 Per Share
-
Reaves Utility Income Fund Announces Regular Monthly Distributions of $0.19 per Share
-
Orchard Therapeutics and Er-Kim Announce Partnership to Broaden Access to Libmeldy to Eligible Patients in Turkey and Certain Eurasian Countries
-
Cybrexa Therapeutics Announces First Patient Dosed with First-in-Class Peptide-Drug Conjugate CBX-12 in Phase 2 Trial in Ovarian Cancer
-
BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit
-
ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff
-
Welltower Announces Date of Third Quarter 2024 Earnings Release, Conference Call and Webcast
-
Blue Owl Capital to Acquire IPI Partners and to Partner with ICONIQ for Future Growth
-
Sodium Butyrate in Viscera-3® Enhances Gut Health and Immune Function for Seasonal Wellness Available During Amazon Prime Day
-
Throat Phlegm Relief from Vitaae®: Natural Support for Women Battling Long COVID and Menopausal Brain Inflammation Available For Amazon Prime Day
-
McDermott Announces Agreement to Sell CB&I Storage Business Line to Consortium of Financial Investors
